Theranica Enters Into Agreement With Dr. Reddy’s for Commercializing Nerivio® in Europe
(Adnkronos) – Commercial Collaboration Follows News of Nerivio®’s Expanded CE Mark Approval as Novel Non-Drug, Dual-Use Migraine Treatment for Adolescents and Adults NETANYA, Israel, Nov. 14, 2023 /PRNewswire/ — Theranica, a neuromodulation therapeutics company, and
